Jinyu Bio Technology Co Stock Current Valuation
| 600201 Stock | 6.72 0.06 0.90% |
Valuation analysis of Jinyu Bio Technology helps investors to measure Jinyu Bio's intrinsic value by examining its available valuation indicators, including the cash flow records, the balance sheet account changes and income statement patterns. At present, Jinyu Bio's Other Cashflows From Investing Activities is projected to increase significantly based on the last few years of reporting. The current year's Total Cashflows From Investing Activities is expected to grow to about 213.3 M, whereas Cash is forecasted to decline to about 884.3 M. Fundamental drivers impacting Jinyu Bio's valuation include:
Price Book 1.3746 | Enterprise Value 6.2 B | Enterprise Value Ebitda 33.472 | Price Sales 5.4938 | Trailing PE 44.1333 |
Overvalued
Today
Please note that Jinyu Bio's price fluctuation is slightly risky at this time. Calculation of the real value of Jinyu Bio Technology is based on 3 months time horizon. Increasing Jinyu Bio's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Jinyu Bio is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Jinyu Stock. However, Jinyu Bio's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 6.72 | Real 5.58 | Hype 6.72 | Naive 6.56 |
The real value of Jinyu Stock, also known as its intrinsic value, is the underlying worth of Jinyu Bio Technology Company, which is reflected in its stock price. It is based on Jinyu Bio's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Jinyu Bio's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Jinyu Bio Technology Co helps investors to forecast how Jinyu stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Jinyu Bio more accurately as focusing exclusively on Jinyu Bio's fundamentals will not take into account other important factors: Jinyu Bio Technology Co Company Current Valuation Analysis
Jinyu Bio's Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current Jinyu Bio Current Valuation | 6.15 B |
Most of Jinyu Bio's fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Jinyu Bio Technology Co is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, Jinyu Bio Technology Co has a Current Valuation of 6.15 B. This is much higher than that of the Biotechnology sector and significantly higher than that of the Health Care industry. The current valuation for all China stocks is notably lower than that of the firm.
Jinyu Current Valuation Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Jinyu Bio's direct or indirect competition against its Current Valuation to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Jinyu Bio could also be used in its relative valuation, which is a method of valuing Jinyu Bio by comparing valuation metrics of similar companies.Jinyu Bio is currently under evaluation in current valuation category among its peers.
Jinyu Fundamentals
| Return On Equity | 0.029 | ||||
| Return On Asset | 0.0098 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 6.15 B | ||||
| Shares Outstanding | 1.12 B | ||||
| Shares Owned By Insiders | 19.79 % | ||||
| Shares Owned By Institutions | 11.95 % | ||||
| Price To Book | 1.37 X | ||||
| Price To Sales | 5.49 X | ||||
| Revenue | 1.6 B | ||||
| Gross Profit | 831.37 M | ||||
| EBITDA | 281.76 M | ||||
| Net Income | 283.63 M | ||||
| Total Debt | 1.22 B | ||||
| Book Value Per Share | 4.70 X | ||||
| Cash Flow From Operations | 414.83 M | ||||
| Earnings Per Share | 0.15 X | ||||
| Target Price | 7.18 | ||||
| Number Of Employees | 1.65 K | ||||
| Beta | 0.57 | ||||
| Market Capitalization | 7.42 B | ||||
| Total Asset | 6.87 B | ||||
| Retained Earnings | 3.16 B | ||||
| Working Capital | 2.18 B | ||||
| Net Asset | 6.87 B | ||||
| Last Dividend Paid | 0.08 |
About Jinyu Bio Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Jinyu Bio Technology Co's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Jinyu Bio using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Jinyu Bio Technology Co based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Jinyu Stock
Jinyu Bio financial ratios help investors to determine whether Jinyu Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Jinyu with respect to the benefits of owning Jinyu Bio security.